Search Results

Dupilumab efficacy may extend to adolescents.

• Authors : Cason, Nia

• Source: Dermatology Times. 2018, Vol. 39, Issue 11, pages. 1

Record details

Specialized skincare improves symptoms.

• Authors : Krader, Cheryl Guttman

• Source: Dermatology Times. 2020, Vol. 41, Issue 9, pages. 1

Record details

Ruxolitinib efficacy, safety data positive.

• Authors : Hilton, Lisette

• Source: Dermatology Times. 2020, Vol. 41, Issue 7, pages. 1

Record details

Study underscores need to improve disease control.

• Authors : Hilton, Lisette

• Source: Dermatology Times. 2020, Vol. 41, Issue 3, pages. 1

Record details

PATIENT DOSING BEGINS FOR PHASE 2 STUDY OF NEW TOPICAL GEL FOR ATOPIC DERMATITIS.

• Source: Dermatology Times. 2018, Vol. 39, Issue 2, pages. 1

Record details

Disease burden high for adolescents.

• Authors : Jesitus, John

• Source: Dermatology Times. 2020, Vol. 41, Issue 4, pages. 2

Record details

Considerations for PsO patients with skin of color: Clinical features may differ QoL impact is significant.

• Authors : Torjesen, Ingrid

• Source: Dermatology Times. 2019, Vol. 40, Issue 11, pages. 2

Record details

Study IDs 'biomarker' for isotretinoin A Es: Insomnia may predict patients vulnerable to psychiatric effects.

• Authors : Petrou, Ilya

• Source: Dermatology Times. 2020, Vol. 41, Issue 8, pages. 1

Record details

Advances promise more personalized care.

• Authors : Hennessy, Mike

• Source: Dermatology Times. 2020, Vol. 41, Issue 2, pages. 1

Record details

Armamentarium grows for advanced BCC: vismodegib study confirms safety, efficacy.

• Authors : Jesitus, John

• Source: Dermatology Times. 2016, Vol. 37, Issue 9, pages. 3

Record details